These bluing compounds can exist as dimeric, trimeric, and tetrameric forms of psilocin and/or its structural analogs.
A recent Nature paper provides novel insights into the neural correlates of the Breakthrough Experience associated with DMT.
Identifying and understanding prodrugs is an essential component of psychedelic drug research.
The study will examine the effects of microdosing LSD on the everyday lives of the participants.
This new crystal form presents new options for developing psychedelics into therapeutic drug formulations.
Real-time gathering of physiological data and subjective effects give clues that may help define a microdose of psilocybin.
Researchers isolate ß-carbolines from several species of Psilocybe.
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
This is the first time psilocybin has been produced from a prokaryotic organism.
New research provides insight into the debate centered around the brain's capacity to synthesize DMT endogenously.